Home
 > Business > Business Daily
Huahai Pharmaceutical Resumes Production
Text Size:A A A 2020-02-17

Zhejiang Huahai Pharmaceutical Co., Ltd. (hereinafter referred to as "Huahai Pharmaceutical") returned to work on February 15 after the outbreak of COVID-19, and its first batch of drugs upon national centralized purchasing were approved to go on market.


With a total of 310,000 boxes, this batch of drugs are mainly antihypertensive agents of Fosinopril and Irbesartan, and are mainly sent to major pharmaceutical sales companies in China. 




【Print】 【Close】
Produced By 大汉网络 大汉版通发布系统